There is 1 paper on gastroesophageal junction adenocarcinoma in aging research: 1 observational study in people.
1 paper studies it2 findings
See all 1 papers on gastroesophageal junction adenocarcinoma
“Overall survival but not disease-free survival was worse for AEG compared to GNCC.”
- Humans1
Effects
2Cleaved PARP1
downin humans1
1 study
Cleaved PARP1
downin humans1
Gastroesophageal junction adenocarcinoma is linked with lower cleaved PARP1 in humans (compared with gastric non-cardia carcinoma).
Humanscompared with gastric non-cardia carcinomaesophagogastric junction
Overall survival
downin humans1
1 study
Overall survival
downin humans1
Gastroesophageal junction adenocarcinoma is linked with lower overall survival in humans (compared with gastric non-cardia carcinoma).
Humanscompared with gastric non-cardia carcinoma
Trial sponsors
Company5 trialsPhase 41,892 people
Company3 trialsPhase 31,276 people
Company2 trialsPhase 32,970 people
Company2 trialsPhase 3948 people
Company1 trialPhase 3780 people
Company1 trialPhase 3515 people
Company1 trialPhase 3490 people
Company1 trialPhase 3479 people